ActiveAging provides an AI-driven platform for Medicare Advantage health plans to proactively manage member benefits and health outcomes. The solution uses data insights and remote monitoring to tailor benefits, aiming to reduce health deterioration and associated financial risks for payers. This end-to-end management system also enhances member engagement to improve retention and satisfaction scores.

CVAid Medical develops an AI-based platform for real-time stroke detection using advanced imaging analysis and machine learning algorithms. This technology enables healthcare providers to quickly identify stroke patients, improving response times and patient outcomes.

The startup develops a minimally invasive implant that utilizes a novel bioelectric technique to treat degenerative disc disease (DDD) by targeting the root cause of the condition. This approach enables physicians to alleviate pain and restore the normal functionality of intervertebral discs.

The startup operates a virtual clinic specializing in the diagnosis and management of complex gynecological conditions through telemedicine and remote patient monitoring. This platform provides patients with access to specialized care, reducing the need for in-person visits and improving health outcomes for those with intricate medical needs.

The startup develops a medical device specifically designed to treat bifurcating and side-wall aneurysms, reducing reliance on anticoagulants while providing enhanced metal coverage. This technology is particularly beneficial for managing ruptured cases, addressing the limitations of existing treatment options in neurovascular care.

Lydus Medical develops the Vesseal™, an automated microvascular suturing device designed for the anastomosis of small blood vessels ranging from 0.5 to 4 mm. This technology reduces ischemic time and operating room duration while enhancing procedural safety and efficiency in cardiovascular, transplant, and reconstructive microsurgery.

Lo provides a platform for managing and automating commercial real estate leasing workflows. It centralizes lease documentation, tracks key dates, and streamlines communication between landlords and tenants. This system helps commercial property managers reduce administrative overhead and ensure compliance across their portfolio.

NovaSight develops AI-driven vision care solutions utilizing eye-tracking technology to provide remote diagnostics and treatment for pediatric vision issues. Their products, including CureSight for amblyopia and TrackSight for myopia management, enhance assessment accuracy and reduce treatment time, enabling children to receive effective care in a comfortable and engaging manner.

Orca Trade provides a decentralized exchange (DEX) built on the Solana blockchain, focusing on efficient and low-cost automated market maker (AMM) liquidity provision. The platform facilitates seamless token swaps and yield generation through concentrated liquidity pools. It offers users a transparent and non-custodial environment for decentralized finance (DeFi) trading activities.

Panacea-ml develops a machine learning-based software system that utilizes predictive analytics to enhance patient selection and trial design for clinical studies in diseases such as ALS, diabetes, and cancer. The platform reduces trial duration and costs while increasing the likelihood of successful market approval for new treatments.

QLOG develops a healthcare management platform that utilizes hybrid Real-Time Location System (RTLS) technology to track equipment location and status, enhancing operational efficiency in hospitals and medical centers. The platform provides real-time data analysis for stakeholders, optimizing workflows and reducing costs while improving patient care quality.

Provides a financial navigation platform that integrates with EMR, pharmacy, and practice management systems to identify and match patients with over 6,000 financial assistance resources, including copay cards and government programs. By streamlining enrollment processes and projecting out-of-pocket costs, it reduces financial barriers to treatment, improving access and affordability for patients across all conditions.

The startup develops immunity-boosting proteins using artificial intelligence, immunology, computational biology, and protein engineering to create safe proteins that do not trigger immune responses. This technology enables physicians to prescribe products that are safe for individuals with food allergies and gluten-related disorders.